- Service Name
Glaukos
- Industry
Healthcare, Medical Devices, Ophthalmology, Eye Care
- Main Value Proposition
Glaukos offers transformative therapies that enhance the treatment of chronic eye diseases, aiming to improve the quality of life for patients and support healthcare providers.
- Description
Glaukos is a company focused on developing innovative therapies for chronic eye diseases, particularly glaucoma, corneal disorders, and retinal diseases. Their mission is to advance the standard of care and improve patient outcomes through novel treatment options.
- Key Features
Innovative glaucoma therapies; Cornea cross-linking interventions; Sustained-release drug delivery platforms for retinal diseases; Comprehensive clinical support and patient education resources
- Use Cases
The service is most valuable in scenarios involving the treatment of glaucoma, corneal disorders, and retinal diseases, particularly for healthcare providers looking to integrate advanced therapies into their practice.
- Competitive advantages
Market-leading portfolio of innovative therapies; Strong commitment to research and development, reinvesting 30% of sales; Comprehensive support and educational resources for healthcare providers
- Strengths
Glaukos's main strengths include its innovative product offerings, strong clinical support, and a dedicated focus on improving patient care through continuous innovation.
- Positioning
Glaukos positions itself as a leader in the ophthalmic market, dedicated to transforming standards of care through innovative therapies and comprehensive support.
- Audience
The target users include ophthalmologists, healthcare providers specializing in eye care, and patients suffering from chronic eye diseases who seek effective treatment options.
- CTA
View Therapies
- Tags
Ophthalmology
Glaucoma
Corneal Disorders
Retinal Diseases
- Tagline
Pioneering New Treatments for Chronic Eye Diseases
- Tone of Voice
Innovative, supportive, dedicated
- Differentiation
Glaukos stands out in the ophthalmic market by focusing on pioneering technologies and therapies that are not only innovative but also backed by significant investment in research and development.
- Brand Positioning
Glaukos identifies itself as a responsible corporate citizen committed to social responsibility and sustainability while focusing on advancing ophthalmic care.
- Founded
1998-01-01
- Founders
Mory Gharib
Olav Bergheim
Richard A. Hill